Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
The original version of this Article omitted the following from the Acknowledgements: ‘This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Breast Cancer Research Program under Award No. W81XWH-15-1-0692. Opinions, interpretations, conclusions a...
Enregistré dans:
Auteurs principaux: | Raffaella Rossin, Ron M. Versteegen, Jeremy Wu, Alisher Khasanov, Hans J. Wessels, Erik J. Steenbergen, Wolter ten Hoeve, Henk M. Janssen, Arthur H. A. M. van Onzen, Peter J. Hudson, Marc S. Robillard |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fea92d6bbdb8481183adf2d4a9442582 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
par: Raffaella Rossin, et autres
Publié: (2018) -
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
par: Wenyan Fu, et autres
Publié: (2019) -
Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
par: Yinghua Zhao, et autres
Publié: (2016) -
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
par: Rodrigo Vazquez-Lombardi, et autres
Publié: (2017) -
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis
par: Christopher S. Lunde, et autres
Publié: (2019)